HIGHLIGHTS
- who: Prostate Cancer et al. from the Department of Urology, Shenzhen Longhua District Central Hospital, The Affiliated Central Hospital of Shenzhen Longhua District, Guangdong Medical University, Shenzhen, Guangdong Province, China have published the paper: Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer, in the Journal: Journal of Oncology 1.0 of 20/03/2022
- what: To sum up, we successfully established a nomogram model based on tyrosine metabolism-related genes and validated the feasibility of this nomogram in independent prostate cancer cohorts.
- how: The authors also . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.